Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice

被引:52
|
作者
Wu, Duo-Jiao [1 ]
Xu, Jian-Zhong [1 ]
Wu, Yong-Jie [1 ]
Jean-Charles, Lafarge [2 ]
Xiao, Bing [1 ]
Gao, Ping-Jin [1 ,3 ]
Zhu, Ding-Liang [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Key Lab Vasc Biol, Shanghai Inst Hypertens,Dept Cellular & Mol Biol, Key Lab Med Genom,Ruijin Hosp,Sch Med, Shanghai 200025, Peoples R China
[2] Sino French Res Ctr Life Sci & Genom, Shanghai, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci Ctr, Lab Vasc Biol, Shanghai, Peoples R China
关键词
Fasudil; Atherosclerosis; Plaque; Micro-ultrasound; Mice; RHO-KINASE; ULTRASOUND; PRAVASTATIN; INHIBITOR; SYSTEM; ARTERY; WALL;
D O I
10.1016/j.atherosclerosis.2009.04.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rho kinases have been shown to be involved in the pathogenesis of atherosclerosis. This study examined the effects of fasudil, a specific Rho kinase inhibitor, on plaque development and progression in atherosclerotic mice. Sixty apolipoprotein E-knockout (apoE-KO) mice were fed a high-fat diet. Mice started to receive fasudil at the same time as fat feeding (early treatment), or after 12 weeks of fat feeding (delayed treatment). In each administrative schedule, mice were divided into three groups: low dose fasudil group (30 mg/kg/day), high dose fasudil group (100 mg/kg/day) and control group (tap water) (n = 10, respectively). Plaque size was determined by using ultrasound biomicroscopy (UBM) and histological examinations. Brachiocephalic artery UBM analysis showed that in early treatment, both doses of fasudil significantly reduced lesion size compared with the controls (P < 0.05). In delayed-fasudil treatment, plaque area was reduced by 54% (P < 0.05) after 12 weeks of treatment at a high dose of fasudil (100 mg/kg/day). The UBM findings were confirmed by histological studies at the corresponding arterial sites. The beneficial effect was also observed in the left common carotid arteries that delayed-fasudil treatment reduced the plaque size in a dose-dependent manner. The arterial intima-medial thickness (IMT) and maximal flow velocity of both arteries were lower in fasudil-treated group (100 mg/kg/day) in comparison with the control mice. Furthermore, fasudil treatment (100 mg/kg/day) reduced the macrophage accumulation in atherosclerotic lesions. However, fasudil had no effects on blood pressure and plasma lipid concentrations in both studies. In conclusion, our studies showed that blocking Rho kinase reduced both the early development and later progression of atherosclerotic plaques in apoE-KO mice by using a novel micro-ultrasound approach. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:68 / 73
页数:6
相关论文
共 50 条
  • [21] Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice
    Hattori, Yoshiyuki
    Hattori, Sachiko
    Wang, Xi
    Satoh, Hiroko
    Nakanishi, Nobuo
    Kasai, Kikuo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (04) : 865 - 870
  • [22] Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice - Inhibitory effect on monocyte chemotaxis
    Pakala, R
    Stabile, E
    Dang, GJ
    Clavijo, L
    Waksman, R
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) : 481 - 486
  • [23] Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice
    Bursill, CA
    Choudhury, RP
    Ali, Z
    Greaves, DR
    Channon, KM
    CIRCULATION, 2004, 110 (16) : 2460 - 2466
  • [24] Late-Stage Captopril Treatment Reduces Atherosclerotic Lesion Progression in Apolipoprotein E Knockout Mice
    Procknow, Jesse David
    Sprague, Randy
    Stephenson, Alan H.
    FASEB JOURNAL, 2009, 23
  • [25] Adenoviral-mediated delivery of a CC-chemokine inhibitor ('35K') attenuates atherosclerotic plaque formation in apolipoprotein E-knockout mice
    Bursill, CA
    Greaves, DR
    Channon, KM
    JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S23 - S24
  • [26] Midkine Promotes Atherosclerotic Plaque Formation Through Its Pro-Inflammatory, Angiogenic and Anti-Apoptotic Functions in Apolipoprotein E-Knockout Mice
    Takemoto, Yoshio
    Horiba, Mitsuru
    Harada, Masahide
    Sakamoto, Kazuma
    Takeshita, Kyosuke
    Murohara, Toyoaki
    Kadomatsu, Kenji
    Kamiya, Kaichiro
    CIRCULATION JOURNAL, 2018, 82 (01) : 19 - 27
  • [27] Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice
    Yang, Jian Min
    Wang, Yan
    Qi, Li Hang
    Wang, Ying
    Gao, Fei
    Ding, Shi Fang
    Ni, Mei
    Liu, Chun Xi
    Zhang, Cheng
    Zhang, Yun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (03) : 602 - 611
  • [28] Combinatorial Interference of Toll-Like Receptor Two and Four Remarkably Stabilizes Atherosclerotic Plaque in Apolipoprotein E-Knockout Mice
    Qi, Li Hang
    Wang, Ying
    Zhang, Cheng
    Ding, Shi Fang
    Ni, Mei
    Feng, Jin Bo
    Zhang, Yun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A423 - A423
  • [29] Reduced atherosclerotic lesion size in P-selectin deficient apolipoprotein E-knockout mice fed a chow but not a fat diet
    Bourdillon, Marie-Claude
    Randon, Jacques
    Barek, Lydie
    Zibara, Kazem
    Covacho, Chantal
    Poston, Robin N.
    Chignier, Elza
    McGregor, John L.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2006,
  • [30] Postnatal Blocking of Interferon-γ Function Prevented Atherosclerotic Plaque Formation in Apolipoprotein E–Knockout Mice
    Mitsuhisa Koga
    Hisashi Kai
    Hideo Yasukawa
    Seiya Kato
    Tomoka Yamamoto
    Yumiko Kawai
    Ken Kusaba
    Yukihiko Seki
    Mamiko Kai
    Kensuke Egashira
    Yasufumi Kataoka
    Tsutomu Imaizumi
    Hypertension Research, 2007, 30 : 259 - 267